4 | SEC Filings Hub

Filing metadata

Accession number: 0001209191-22-003317
Form type: Form 4
Filer: LA JOLLA PHARMACEUTICAL CO
CIK: CIK 920465
Filed: Jan 14, 2022
Reporting period: Jan 12, 2022
Description: Insider transaction

Documents

0001209191-22-003317-index.htm

Complete submission

0001209191-22-003317.txt

directory listing

Filed by

LA JOLLA PHARMACEUTICAL CO